<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200501047254N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-23</date_registration>
      <primary_sponsor>Gonabad University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the Effect of Hypothermia Prevention Program in Children Undergoing Orthopedic Surgery</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Effect of Hypothermia Prevention Program on, Recovery Time, Shivering and Hemodynamic Status in Pediatric Undergoing Orthopedic Surgery Under General Anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-03-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62017</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Prevention, Randomization description: The sampling method is simple randomization. For random allocation of participants, 60 envelopes are prepared and in each envelope the names of groups, A or B are placed evenly. Then the patient with the inclusion criteria randomly selects an envelope and according to the name of the group that if A was in the intervention group and if B was in the control group and until the last sample will be done in the same way and the necessary measures for the group Will be done, Blinding description: This study is a single blind. So that the patient is not aware of the type of measures that will be performed for him, but since the measurement of parameters is done by the researcher, the researcher does not blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Hypothermia of newborn. Condition 2: Hypothermia.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Performing routine care in the operating room to maintain the patient's temperature and prevent hypothermia. Intervention 2: Intervention group: In this group, heated solutions up to 32 ° C are used for skin disinfection, heated solutions up to 37 ° C are used for intravenous infusion, and before transferring the patient to recovery, the recovery bed and blanket will be heated by the warmer.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The results of the study will be published along with the working method and executive protocols after the end of the study. Patients' personal information will be kept secure and only the results of the intervention will be available.

When:
Access period starts from the second half of 1401

To whom:
Researchers working in academic and scientific institutions

Conditions:
Only the results of the study will be available for other researchers to cite.

Where to obtain:
Author responsible for the scientific study

How to obtain:
Contact the responsible author via email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Pouladkhay</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Operating Room, School of Paramedical Sciences, Gonabad University of Medical Sciences, Gonabad, Khorasan Razavi</address>
        <city>Gonabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9691793718</zip>
        <telephone>+98 51 5722 3028</telephone>
        <email>pouladkhay.fatemeh@gmail.com</email>
        <affiliation>Gonabad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Pouladkhay</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Operating Room, School of Paramedical Sciences, Gonabad University of Medical Sciences, Gonabad, Khorasan Razavi</address>
        <city>Gonabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9691793718</zip>
        <telephone>+98 51 5722 3028</telephone>
        <email>pouladkhay.fatemeh@gmail.com</email>
        <affiliation>Gonabad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children undergoing surgery with a minimum time of 30 minutes
Age 3 to 18 years
The patients who are candidate for general anesthesia
Patients with ASA class 1 and 2
Body temperature 36.5 to 37 ° C
No drug addiction
Reluctance to continue participating in the project</inclusion_criteria>
      <agemin>3 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Occurrence of any condition that affects the patient's normal course of anesthesia and surgery, such as excessive bleeding and cardiac arrest during surgery
Significant decrease in blood pressure during surgery (20% decrease in blood pressure compared to before anesthesia)
Temperatures above 37.5 ° C or below 36 ° C before surgery
Receiving blood and blood products during surgery
Take corticosteroids
Receiving non-steroidal analgesics and magnesium sulfate
Prohibition to control body temperature through the tympanic membrane
Receiving drugs other than fentanyl during surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code>P80</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword>Hypothermia of newborn</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Performing routine care in the operating room to maintain the patient's temperature and prevent hypothermia</i_keyword>
      <i_keyword>Intervention group: In this group, heated solutions up to 32 ° C are used for skin disinfection, heated solutions up to 37 ° C are used for intravenous infusion, and before transferring the patient to recovery, the recovery bed and blanket will be heated by the warmer.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Hypothermia. Timepoint: The measurement of the variable in eight shifts will include the following: 5 minutes before the start of anesthesia, 5 minutes after induction of anesthesia and one minute before the start of surgery, 30 minutes after the start of surgery, after the end of surgery, at the beginning of recovery, 30  minutes and 1 hour after transferring the patient to recovery will be monitored. Method of measurement: Tympan thermometer.</prim_outcome>
      <prim_outcome>Hemodynamic status. Timepoint: The measurement of the variable in eight shifts will include the following: 5 minutes before the start of anesthesia, 5 minutes after induction of anesthesia and one minute before the start of surgery, 30 minutes after the start of surgery, after the end of surgery, at the beginning of recovery, 30  minutes and 1 hour after transferring the patient to recovery will be monitored. Method of measurement: Anesthesia monitor.</prim_outcome>
      <prim_outcome>Shivering. Timepoint: The measurement of the variable at the beginning of recovery, 30  minutes and 1 hour after transferring the patient to recovery will be monitored. Method of measurement: Mahajan and Crossley criteria will be used to evaluate the incidence of postoperative shivering. The number zero indicates the patient without shivering, the number 1 = mild shivering (hair straightening), the number 2 = moderate shivering (muscle tremors visible in one group of muscles), the number 3 = severe shivering) muscle tremors in more than one group of Muscles but not in the whole body (generalized) and the number 4 - will show very strong vibration (generalized body vibration).</prim_outcome>
      <prim_outcome>Recovery time. Timepoint: From the moment of arrival until the patient is discharged from recovery. Method of measurement: Timer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gonabad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-24</approval_date>
        <contact_name>Ethics Committee of Gonabad University of Medical Sciences</contact_name>
        <contact_address>Operating Room Department, School of Paramedical Sciences, Gonabad University of Medical Sciences, Asian Roadside, Gonabad Gonabad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
